Metabolic Health

Diabetes
Blood Test

Type 2 diabetes does not appear overnight. Insulin resistance develops over 5 to 15 years before glucose levels become abnormal. The standard NHS test catches the disease. The right private test catches the trajectory, years earlier, when it is still reversible.

The Timeline

How type 2 diabetes actually develops

Understanding the timeline explains why standard tests catch diabetes late and why insulin testing catches it early.

Stage 1: Insulin resistance begins (years 0-5)

Your cells start responding less efficiently to insulin. Your pancreas compensates by producing more insulin. Fasting glucose and HbA1c remain completely normal because the extra insulin keeps blood sugar controlled. A standard test shows nothing wrong. Fasting insulin and HOMA-IR are elevated, clearly showing the pancreas is working overtime. This is the stage where dietary and lifestyle changes are most effective.

Stage 2: Compensation starts failing (years 5-10)

The pancreas struggles to keep up. Fasting glucose starts creeping up but may still sit within the "normal" reference range. HbA1c edges towards the upper end of normal. Post-meal glucose spikes become more pronounced. Insulin levels are significantly elevated. HOMA-IR is clearly abnormal. A standard test might note "borderline" glucose. An insulin-inclusive test shows the metabolic dysfunction clearly.

Stage 3: Pre-diabetes (years 8-15)

HbA1c reaches 42 to 47 mmol/mol. Fasting glucose is 5.5 to 6.9 mmol/L. This is where the NHS first flags a problem. By this point, insulin resistance has been present for years, and pancreatic beta-cell function has already declined significantly. Lifestyle changes still work but the window is narrower.

Stage 4: Type 2 diabetes diagnosis (years 10-20)

HbA1c reaches 48 mmol/mol or above. Fasting glucose exceeds 7.0 mmol/L. By now, beta-cell function has declined substantially. Medication is typically required alongside lifestyle changes. This is where the standard NHS pathway diagnoses the condition, often a decade or more after the process began.

The gap between Stage 1 and Stage 3 can be 5 to 15 years. During that entire period, the only way to detect the problem is by testing fasting insulin. The NHS does not do this routinely. Most private blood testing services do not either.

The Markers

Five markers for a complete metabolic picture

MarkerWhat It ShowsWhen It Becomes AbnormalNHS?TrueVitals?
Fasting glucoseBlood sugar at the time of the testLate: only rises once insulin can no longer compensateYesAll panels
HbA1cAverage blood sugar over 2-3 monthsLate: reflects glucose levels, not insulin levelsYesAll panels
Fasting insulinHow much insulin your pancreas is producing to control glucoseEarly: rises years before glucose does as the pancreas compensatesNoUltimate
HOMA-IRCalculated insulin resistance score (insulin x glucose / 22.5)Early: quantifies resistance directlyNoUltimate (calculated)
C-PeptideMarker of endogenous insulin production (not affected by exogenous insulin)Early to mid: confirms pancreatic insulin output independentlyRarelyUltimate

TrueVitals also calculates HOMA-B (beta-cell function) and the triglyceride/HDL ratio, which is one of the best surrogate markers for insulin resistance. Your report cross-references all metabolic markers with your body composition data, dietary patterns, and exercise habits from the lifestyle quiz.

Risk Factors

Who should test for insulin resistance

Anyone can develop insulin resistance, but certain factors increase the likelihood. If any of these apply to you, testing fasting insulin and HOMA-IR is particularly valuable.

Family history

A parent or sibling with type 2 diabetes significantly increases your risk. Genetics account for 40 to 70% of insulin resistance susceptibility. Early testing reveals whether you are on the same trajectory.

Excess abdominal fat

Visceral fat around the abdomen is the strongest physical predictor of insulin resistance. Waist circumference above 94cm (men) or 80cm (women) warrants metabolic testing. The Signature panel includes waist measurement.

PCOS

Polycystic ovary syndrome and insulin resistance are closely linked. Up to 70% of women with PCOS have insulin resistance. Testing insulin and HOMA-IR is essential for PCOS management alongside reproductive hormones.

Sedentary lifestyle or high-carb diet

Physical inactivity and excessive refined carbohydrate intake are the most modifiable risk factors. Testing provides the data to see whether your current lifestyle is maintaining insulin sensitivity or eroding it.

High triglycerides or low HDL

A triglyceride/HDL ratio above 2.0 (mmol/L) is one of the best surrogate markers for insulin resistance. If your previous cholesterol test showed this pattern, insulin testing adds the metabolic depth.

Fatigue, brain fog, or energy crashes

Blood sugar dysregulation from insulin resistance causes energy peaks and crashes, brain fog after meals, afternoon fatigue, and sugar cravings. These are the earliest subjective symptoms, often dismissed as normal.

What Your Results Mean

Interpreting your metabolic results

HOMA-IR below 1.0

Excellent insulin sensitivity. Your metabolic health is strong. Maintain your current lifestyle and retest annually to track trends.

HOMA-IR 1.0 to 2.0

Mildly elevated. Early insulin resistance may be developing. This is the ideal window for intervention. Dietary changes (reducing refined carbohydrates, increasing protein and fibre), regular exercise, and improved sleep quality can reverse the trajectory. Retest in 6 months.

HOMA-IR 2.0 to 3.0

Moderate insulin resistance. Your pancreas is working significantly harder than it should to maintain normal glucose. Targeted intervention is recommended. Your TrueVitals report provides specific dietary, exercise, and supplementation recommendations. Consider sharing your results with your GP. Retest in 3 to 6 months.

HOMA-IR above 3.0

Significant insulin resistance. High risk of progression to pre-diabetes if not addressed. GP referral is recommended. Your report provides the data your doctor needs to make informed clinical decisions. Lifestyle intervention remains the primary treatment but medical support may be beneficial.

Your TrueVitals report does not just flag the number. It cross-references your insulin with your triglyceride/HDL ratio, body composition data, dietary patterns, exercise habits, and inflammatory markers to explain the full metabolic picture and give you a targeted action plan.

The Bigger Picture

Why metabolic testing alone is not enough

Insulin resistance does not exist in isolation. It drives a cascade of problems across multiple health systems.

It raises triglycerides and lowers HDL (cardiovascular risk). It increases SHBG production changes that affect sex hormone availability. It promotes chronic low-grade inflammation (hs-CRP). It alters thyroid-binding proteins. It accelerates visceral fat accumulation. It contributes to fatty liver disease (elevated ALT/GGT).

A standalone metabolic test gives you insulin and glucose without showing you the downstream effects. A TrueVitals Ultimate panel shows you the metabolic markers alongside cardiovascular risk (ApoB, triglyceride/HDL ratio), liver function (ALT, GGT), hormones (testosterone, SHBG), thyroid, and inflammation. Your report connects all of them. See how our reports work.

FAQs

Common questions

Fasting insulin and HOMA-IR detect insulin resistance years before HbA1c or glucose become abnormal. The NHS tests HbA1c and glucose, which only flag a problem once insulin resistance has been present for 5 to 15 years. TrueVitals Ultimate includes fasting insulin, HOMA-IR, C-peptide, HbA1c, and fasting glucose for the complete metabolic picture.

No. The NHS uses HbA1c and fasting glucose for diabetes screening. Fasting insulin and HOMA-IR are not routinely available through NHS primary care. A private comprehensive blood test is the most reliable way to assess insulin resistance in the UK. NHS vs private comparison.

Yes, particularly in the early stages. Reducing refined carbohydrates, increasing protein and fibre intake, regular exercise (both resistance and aerobic), improving sleep quality, and managing stress can all improve insulin sensitivity. The earlier it is detected, the more responsive it is to lifestyle intervention. This is why testing fasting insulin matters.

Below 1.0 is optimal. 1.0 to 2.0 is mildly elevated. 2.0 to 3.0 indicates moderate insulin resistance. Above 3.0 indicates significant resistance with elevated diabetes risk. Your TrueVitals report categorises your result with specific recommendations for your level.

Yes. Fasting for 8 to 12 hours before a morning blood draw is essential for accurate glucose and insulin measurements. HbA1c is not affected by fasting but the other metabolic markers are. Water is fine during the fast.

Catch insulin resistance before it becomes diabetes

Fasting insulin, HOMA-IR, C-peptide, HbA1c, and glucose. Plus 109 other markers for the complete metabolic and health picture. £349.